Recent developments include leadership changes, workforce reductions, and policy shifts at HHS and FDA, reshaping agency operations under President Trump’s administration.

By Nathan A. Beaton, Jennifer L. Bragg, William A. McConagha, and Trevor Thompson

Since his inauguration, President Trump has focused on reshaping federal agencies through a series of executive orders intended to reduce the size of the federal workforce and dramatically alter the landscape in which agencies operate. In turn, Department of Health and Human Services

New rounds of cuts and organizational shifts for HHS staff and operating divisions could dramatically impact the healthcare and life sciences industry.

By Nathan A. Beaton, Joseph C. Hudzik, Elizabeth M. Richards, and Anton Lesaca

On April 1, 2025, the US Department of Health and Human Services (HHS) began implementing a significant reduction in force (RIF) of staff, five days after HHS Secretary Robert F. Kennedy, Jr. announced plans for a “dramatic restructuring” of the department and

The future of GRAS: FDA considers new rules that could impact food product innovation.

By William A. McConagha, Meryl Bartlett, and Trevor Thompson

On March 10, 2025, Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. announced in a press release that he has directed the Food and Drug Administration (FDA) to explore rulemaking to implement a seismic shift in how most companies introduce ingredients into the nation’s food supply. The shift would eliminate the

The policy statement aims to bring more rapid action on personnel and management decisions and empowers HHS and each of its offices and subagencies to promulgate or rescind certain rules without a period of notice and comment rulemaking.

By Nathan A. Beaton, Jason B. Caron, Eric C. Greig, William A. McConagha, and Elizabeth M. Richards

On March 3, 2025, the Department of Health and Human Services (HHS), under the leadership of Secretary Robert F. Kennedy